38
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn’s disease in the United States

, , , &
Pages 501-512 | Published online: 06 Dec 2013

References

  • HerrintonLJLiuLLafataJEEstimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensingsInflamm Bowel Dis200713445146117219403
  • KappelmanMDRifas-ShimanSLKleinmanKThe prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United StatesClin Gastroenterol Hepatol20075121424142917904915
  • PrefontaineEMacdonaldJKSutherlandLRAzathioprine or 6-mercaptopurine for induction of remission in Crohn’s disease [review]Cochrane Database Syst Rev20106CD00054520556747
  • PrefontaineESutherlandLRMacdonaldJKCepoiuMAzathioprine or 6-mercaptopurine for maintenance of remission in Crohn’s disease [review]Cochrane Database Syst Rev20091CD00006719160175
  • PresentDHKorelitzBIWischNGlassJLSacharDBPasternackBSTreatment of Crohn’s disease with 6-mercaptopurine. A long-term, randomized, double-blind studyNew Engl J Med1980302189819876102739
  • CandySWrightJGerberMAdamsGGerigMGoodmanRA controlled double blind study of azathioprine in the management of Crohn’s diseaseGut19953756746788549944
  • DerijksLJGilissenLPHooymansPMHommesDWReview article: thiopurines in inflammatory bowel diseaseAliment Pharmacol Ther200624571572916918876
  • MantzarisGJChristidouASfakianakisMAzathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn’s diseaseInflamm Bowel Dis200915337538219009634
  • ReinischWPanésJLémannMA multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn’s diseaseAm J Gastroenterol200810392284229218671816
  • MarkowitzJGrancherKKohnNLesserMDaumFA multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn’s diseaseGastroenterology2000119489590211040176
  • HaCYUllmanTASiegelCAKornbluthAAre patients enrolled in randomized controlled trials (RCTs) representative of the general inflammatory bowel disease (IBD) patient population?Gastroenterology20111405 Suppl 1S113
  • StromBLTextbook of Pharmacoepidemiology4 edChichesterJohn Wiley and Sons Ltd2005
  • FraserAGOrchardTRJewellDPThe efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year reviewGut200250448548911889067
  • GoodhandJRTshumaNRaoADo children with IBD really respond better than adults to thiopurines?J Pediatr Gastroenterol Nutr201152670270721593643
  • RielloLTalbotecCGarnier-LenglinéHTolerance and efficacy of azathioprine in pediatric Crohn’s diseaseInflamm Bowel Dis201117102138214321910176
  • HyamsJSKimMODensonLEarly anti-TNFα therapy is superior to early immunomodulator therapy in newly diagnosed children with Crohn’s diseaseGastroenterology20131445S146
  • US Food and Drug AdministrationNational Drug Code Database Background InformationSilver Spring, MDUS Food and Drug Administration2012 [June]. Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/UCM070829Accessed November 6, 2013
  • RayWAEvaluating medication effects outside of clinical trials: new-user designsAm J Epidemiol2003158991592014585769
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • HerrintonLJLiuLFiremanBTime trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998–2005Gastroenterology2009137250251119445944
  • PunatiJMarkowitzJLererTPediatric IBD Collaborative Research GroupEffect of early immunomodulator use in moderate to severe pediatric Crohn diseaseInflamm Bowel Dis200814794995418306311
  • HyamsJSMarkowitzJFCan we alter the natural history of Crohn disease in children?J Pediatr Gastroenterol Nutr200540326227215735477
  • LewisJDIs there still a rationale for monotherapy after SONIC and SUCCESS?AGA Perspectives20117657 Available from: http://www.gastro.org/mobiletools/news-item/1297Accessed October 22, 2012
  • MelesseDYTargownikLESinghHPatterns of drug avoidance in patients with inflammatory bowel diseaseGastroenterology20131445S48S49
  • ChaparroMOrdásICabréESafety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patientsInflamm Bowel Dis20131971404141023665964